Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Prognostic Role of Brain MRI in Anti-LGI1 Encephalitis

NCT05825690 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT05825690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05825690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Prognostic Role of Brain MRI in Anti-LGI1 Encephalitis
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Completed
Start date
June 20, 2022
Completion date
December 20, 2022
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune encephalitis